All Pharma News
Marinus Pharmaceuticals To Report Q2 2024 Results On August 13

Marinus Pharmaceuticals To Report Q2 2024 Results On August 13
BUSINESSWIRE
30 Jul 2024
Share Share
Ganaxolone Approved In China For CDKL5 Deficiency Disorder Seizures

Ganaxolone Approved In China For CDKL5 Deficiency Disorder Seizures
BUSINESSWIRE
18 Jul 2024
Share Share
Marinus reports mixed Phase 3 results on IV seizure drug

Marinus reports mixed Phase 3 results on IV seizure drug
Kevin Dunleavy FIERCE PHARMA
18 Jun 2024
Share Share
With investor lawsuit and trial flop, troubles mount for Marinus

With investor lawsuit and trial flop, troubles mount for Marinus
FIERCE PHARMA
17 Jun 2024
Share Share
Marinus Pharma Announces Topline Results From Phase 3 RAISE Trial Of Ganaxolone

Marinus Pharma Announces Topline Results From Phase 3 RAISE Trial Of Ganaxolone
BUSINESSWIRE
17 Jun 2024
Share Share
Marinus Announces Updates For Tuberous Sclerosis Program

Marinus Announces Updates For Tuberous Sclerosis Program
BUSINESSWIRE
17 May 2024
Share Share
Marinus Pharmaceuticals: Business Update, Q1 2024 Financials

Marinus Pharmaceuticals: Business Update, Q1 2024 Financials
BUSINESSWIRE
08 May 2024
Share Share
Marinus lays off 20% to steady ship after IV seizure med issues

Marinus lays off 20% to steady ship after IV seizure med issues
James Waldron FIERCE BIOTECH
08 May 2024
Share Share
Marinus To Present At RBC Healthcare Conference 2024

Marinus To Present At RBC Healthcare Conference 2024
BUSINESSWIRE
02 May 2024
Share Share
Marinus Q1 2024 Results, Business Update On May 8

Marinus Q1 2024 Results, Business Update On May 8
BUSINESSWIRE
01 May 2024
Share Share